Zaremba, Anne ; Mohr, Peter ; Gutzmer, Ralf ; Meier, Friedegund 
; Pföhler, Claudia ; Weichenthal, Michael ; Terheyden, Patrick ; Forschner, Andrea ; Leiter, Ulrike ; Ulrich, Jens ; Utikal, Jochen ; Welzel, Julia ; Kaatz, Martin ; Gebhardt, Christoffer ; Herbst, Rudolf ; Sindrilaru, Anca ; Dippel, Edgar ; Sachse, Michael ; Meiss, Frank ; Heinzerling, Lucie ; Haferkamp, Sebastian ; Weishaupt, Carsten ; Löffler, Harald ; Kreft, Sophia ; Griewank, Klaus ; Livingstone, Elisabeth ; Schadendorf, Dirk ; Ugurel, Selma ; Zimmer, Lisa
; Pföhler, Claudia ; Weichenthal, Michael ; Terheyden, Patrick ; Forschner, Andrea ; Leiter, Ulrike ; Ulrich, Jens ; Utikal, Jochen ; Welzel, Julia ; Kaatz, Martin ; Gebhardt, Christoffer ; Herbst, Rudolf ; Sindrilaru, Anca ; Dippel, Edgar ; Sachse, Michael ; Meiss, Frank ; Heinzerling, Lucie ; Haferkamp, Sebastian ; Weishaupt, Carsten ; Löffler, Harald ; Kreft, Sophia ; Griewank, Klaus ; Livingstone, Elisabeth ; Schadendorf, Dirk ; Ugurel, Selma ; Zimmer, Lisa Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG
Article
Zaremba, Anne, Mohr, Peter, Gutzmer, Ralf, Meier, Friedegund, Pföhler, Claudia, Weichenthal, Michael, Terheyden, Patrick, Forschner, Andrea, Leiter, Ulrike, Ulrich, Jens, Utikal, Jochen, Welzel, Julia, Kaatz, Martin, Gebhardt, Christoffer , Herbst, Rudolf, Sindrilaru, Anca, Dippel, Edgar, Sachse, Michael, Meiss, Frank , Heinzerling, Lucie, Haferkamp, Sebastian, Weishaupt, Carsten, Löffler, Harald, Kreft, Sophia, Griewank, Klaus, Livingstone, Elisabeth, Schadendorf, Dirk, Ugurel, Selma and Zimmer, Lisa
(2023)
Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG.
European Journal of Cancer 188, pp. 140-151.
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | European Journal of Cancer | ||||
| Publisher | ELSEVIER SCI LTD | ||||
| Place of Publication | OXFORD | ||||
| Volume | 188 | ||||
| Page Range | pp. 140-151 | ||||
| Date | 2023 | ||||
| Date of publication | 18 Mar 2025 10:11 | ||||
| Institutions | Medicine > Lehrstuhl für Dermatologie und Venerologie | ||||
| Identification Number |
| ||||
| Keywords | STAGE-III; IPILIMUMAB; NIVOLUMAB; MUTATIONS; BRAF; SURVIVAL; Melanoma; Immune checkpoint inhibitors; Immunotherapy | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 76270 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric